![](https://investorshub.advfn.com/uicon/83357.png?cb=1596264753)
Sunday, September 20, 2020 6:09:19 AM
Quote: "But, they need to find a use beyond COVID 19 because the window on that is pretty short, 5 years max,"
Have you any inkling as to how much can occur with Revive in that timeframe, especially if/when Bucillamine and it's other drug treatments prove to be successful?
In addition, from a purely fiscal perspective, many who got in at these levels or lower, will most likely not be here in 5 years as they would have long "cashed out" before that.
That statement was so clearly not well thought out, I couldn't believe you actually stated it publicly.
2020!!!!!
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM